Table 3. Comparison of Response Parameters Between Group A and Group B Naive Patients^a,b.

	Total c	Group A c	Group B c	OR (CI 95%) d	P Value
RVR	168/248 (67.7)	147/214 (68.7)	21/34 (61.8)	1.36 (0.64 - 2.87)	0.42 e
EVR	231/255 (90.6)	201/220 (91.4)	30/35 (85.7)	1.76 (0.61 - 5.07)	0.29 e
SVR	173/211 (82.0)	150/184 (81.5)	23/27 (85.2)	0.77 (0.25 - 2.36)	0.79 f
Resistance	14/261 (5.4)	12/226 (5.3)	2/35 (5.7)	0.93 (0.20 - 4.32)	0.92 e
Relapse	24/197 (12.2)	22/172 (12.8)	2/25 (8.0)	1.69 (0.37 - 7.66)	0.75 f
Withdrawal	29/263 (11.0)	25/228 (11.0)	4/35 (11.4)	0.95 (0.31 - 2.93)	0.94 e

^aAbbreviations: EVR, Rapid Viral Response; RVR, Rapid Viral Response; SVR, Sustained Viral Response.

^bGroup A treated with Peginterferon-alpha-2a and Group B treated with Peginterferon-alpha-2b both in combination with Ribavirin.

^cData are presented as No. of cases/No. of all. (%).

^dOdds Ratio of Group A/Group B (95% Confidence Interval).

^ePearson Chi-Square.

^fFisher’s Exact test.